Title : Bronchopulmonary Dysplasia: Myths of Management
Abstract:
Abstract: Bronchopulmonary dysplasia (BPD) is the most common and important respiratory morbidity of prematurity, affecting thousands of infants worldwide annually. In this presentation, I will highlight the significance of BPD from both individual and societal perspectives, discuss the pulmonary injury sequence, and explore the myths of management, including epidemiologic, ventilatory, and pharmacologic aspects. The latter will include diuretics, bronchodilators, corticosteroids, anti-reflux medications, and others, with a review of the available evidence base. A brief look at agents under current investigation will also be provided.
What will audience learn from your presentation?
- Understand the changing epidemiology of BPD
- Comprehend the multifactorial bases of the pulmonary injury sequence
- Realize that infants with BPD are exposed to a myriad of pharmaceutical agents with dubious efficacy and questionable safety.